Status:
COMPLETED
Prevention and Risk: Treatment With a New Emphasis on Relationships
Lead Sponsor:
Hunter College of City University of New York
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Adherence, Medication
Risk Reduction
Eligibility:
MALE
18-29 years
Phase:
NA
Brief Summary
This research examines the efficacy of an individually-delivered intervention tailored for YMSM in relationships. The intervention - termed PARTNER - utilizes a brief (4 session) motivational intervie...
Detailed Description
This study aims to evaluate a individual-focused intervention with an integrated focus on drug use and HIV prevention, including uptake of and adherence to PrEP. The investigators will recruit a sampl...
Eligibility Criteria
Inclusion
- 18 to 29 years of age (inclusive);
- Main partner must be aged 18 or older.
- Must be in a main partner relationship with another male (duration ≥ 1 months);
- HIV-negative serostatus (confirmed by rapid test);
- Recent (past 30 day) use of at least one of the substances identified as most commonly used by YMSM (marijuana, cocaine, methamphetamine, heroin or other opiates, MDMA, psychedelics, GHB, and/or ketamine);
- Sexual behavior meeting CDC criteria for PrEP candidacy (TRB with a casual partner in the past 30 days or TRB with a non-monogamous or serodiscordant main partner).
- Participants must reside in the NYC metro area
- Ability to communicate in English
Exclusion
- Unstable, serious psychiatric symptoms (assessed by the Psychotic Disorder subsection of the Structured Clinical Interview for DSM-IV);
- Current suicidal/homicidal ideation;
- Evidence of gross cognitive impairment (a score of \<24 on the mini-mental state examination)
- A history of severe physical or sexual Intimate Partner Violence (IPV) victimization in the current relationship in which participants report not currently feeling "safe" in their relationship and/or coerced to participate in the study.
Key Trial Info
Start Date :
February 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 21 2024
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT03396367
Start Date
February 14 2018
End Date
February 21 2024
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunter College- City University of New York
New York, New York, United States, 10018